Welcome to our dedicated page for Neutrisci International news (Ticker: NRXCF), a resource for investors and traders seeking the latest updates and insights on Neutrisci International stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Neutrisci International's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Neutrisci International's position in the market.
NeutriSci International Inc. (OTCQB: NRXCF) announced a new order from Tabletz LLC for its TABLETZ product, to be delivered to a retailer in Japan. This order builds on a multi-million dollar contract for a nationwide launch in the country, involving several thousand 3-tab sticks in Mint, Lemon, and Berry flavors. Scheduled for shipment between late May and early June 2021, this rush order aims to support a 'first-to-market' strategy. CEO Glen Rehman emphasized the strengthening of their partnership with Tabletz in fulfilling this request.
NeutriSci International Inc. (OTCQB: NRXCF) has completed its new production line and research facility in Las Vegas, designed for the production and development of nutraceutical products. Spanning over 8,000 square feet, the facility can currently produce 140,000 tabs per shift, representing only 35% of its full capacity. This strategic move allows for better intellectual property protection, efficient product formulation, and the ability to offer contract manufacturing services. The facility is expected to support co-branding opportunities and enhance revenue generation, especially with forthcoming shipments to Japan.
NeutriSci International Inc. (OTCQB: NRXCF) announced that its partner, Tabletz LLC, has received approval for a Harmonized Code from Japanese customs for the TABLETZ product line. This classification facilitates the product's import into Japan, targeting 46,000 distribution locations. The TABLETZ product includes 3- and 7-tab sticks in various flavors, with a bulk bottle format planned. NeutriSci anticipates significant market potential, as Japan is set to become a leading medical cannabis market in Asia, valued at $800 million USD.
NeutriSci International (OTCQB: NRXCF) announces an upcoming official launch of its TABLETZ brand in Japan on November 4-5, following a successful soft launch that attracted around 3,000 attendees. The product received positive feedback for its taste, packaging, and pricing. Distribution is set for 46,000 stores across Japan, including 7-Eleven and K.K. Lawson. NeutriSci is ramping up production and logistics while preparing new bulk packaging options. CEO Glen Rehman expressed confidence in their growth strategy, emphasizing strong support from various stakeholders in Japan.
NeutriSci International (OTCQB: NRXCF) announced a new partnership with Cryopharm Corp. to distribute its CBD and THC products in Washington state, set to begin in December 2020. Following a successful launch in California, over 400 dispensaries will carry NeutriSci's product line, which includes Marbl Melts™, Kali Juice™, Kushtabs™, and Zenstix™. Washington, the second-largest recreational cannabis market globally, saw sales surpass $1 billion in 2019, providing significant growth potential for NeutriSci.
NeutriSci International Inc. (OTCQB: NRXCF) is launching the TABLETZ brand in Japan this month through its partnership with Tabletz LLC. The product line includes two SKUs: a 'Daily' stick with three 14 mg CBD TABLETZ priced at $8.00 USD and a 'Travel' stick with seven 14 mg TABLETZ for $16.00 USD. Both products come in three flavors: Berry, Lemon, and Mint. Additionally, a 500 mg bulk bottle will be available soon. The initial product unveiling will occur at a VIP media event on October 8-9, 2020.
NeutriSci International Inc. has announced a significant soft-launch event for its new product in Japan scheduled on October 8-9, 2020, expecting around 3,000 attendees. The company is also readying product sales in California following successful testing. NeutriSci raised $381,400 through a private placement, with plans to enhance production capacity and support the Japan launch. Both developments signal a strategic push into international markets and increased manufacturing capabilities.
NeutriSci International Inc. (OTCQB: NRXCF) announced new product launches, including the cannabis-infused Kali Juice, targeting the California market in October 2020. The company is extending its product line beyond existing offerings with plans to enter 600 dispensaries. NeutriSci confirmed revenue from initial orders in Japan will appear in Q3 reports but also indicated delays in packaging approvals due to COVID-19. CEO Glen Rehman remains optimistic about market expansions, emphasizing the company's commitment to overcoming operational challenges.
NeutriSci International (NRXCF) announced its partnership with Cryopharm Corp. to distribute CBD and THC products across over 90 dispensaries in Southern California, with plans to expand to 350 by Q4-2020. Key products include Zenstix and Kushtabs, which feature a rapid activation time of 12 minutes. The CEO, Glen Rehman, noted that despite COVID-19 limitations, production capacity is increasing and initial orders are being secured. The expansion aims to enhance revenue streams and shareholder value while maintaining sales targets globally.